A meeting of Australia’s dispensers held during the O=MEGA19 conference in July 2019 highlighted that the profession suffers from lack...
Read moreDetailsThe deal will see Novartis pay US$3.4 billion (AU$4.8 b) cash upfront with potential milestone payments of up to US$1.9...
Read moreDetailsLed by the Centre for Eye Research Australia’s (CERA) Professor Mingguang He and Research Fellow Dr Stuart Keel, the trial...
Read moreDetailsShould optometrists move down the path of population-based screening programs, or does a more judicious, targeted approach ensure the best...
Read moreDetailsTo battle the sector’s biggest players, Safilo is positioning its eyewear collection as the feather in independent optometry’s cap. COLEBY...
Read moreDetailsAs useful as it can be, performing OCT on every patient who walks through the doors of a primary eyecare...
Read moreDetailsIn the same way OCT should not be used in isolation to assess glaucoma, Specsavers’ nationwide OCT rollout also should...
Read moreDetailsThe development and now widespread availability of OCT has altered diagnosis and management of ocular disease, particularly age-related macular degeneration...
Read moreDetailsDuring the past decade and a half OCT has evolved from a research tool into something that is widely and...
Read moreDetailsEmbracing new technology that improves early detection, digital referrals, treatment options and adherence is key to enhancing patient-centred collaborative care....
Read moreDetailsInsight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.
© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited
© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited